Increasing number of drug discoveries is expected to drive the growth of global Cell Based Assays in the forecast period, 2024-2028.
According to TechSci Research report, “Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the global cell-based assays market is anticipated to grow at an impressive rate in the forecast period 2024-2028. This can be ascribed to the increasing demand for identification and optimization procedures in drug development along with the rapid adoption of cell-based assays by biopharmaceutical companies across the globe. Additionally, technological advancements in the end users for cell-based assays and introduction of new drugs especially in the developed countries in the North America and Europe, altogether, are expected to create lucrative opportunities for the market growth in the coming years. Besides, increasing investment for research and demand for manufacturing of cell-based assay products in underdeveloped and developing countries are further expected to support the market growth. Similarly, in biomedical research screening for biological activity and biochemical mechanisms, and off-target interactions for a molecule is anticipated to boost the market growth during the forecasted year. Also, many private firms offer customized assays that suit individual research need a focus on a therapeutic regime to combat a particular disease which will further drive the market growth during the forecasted years.
However, increasing usage of expensive systems and high price of the instruments often reduce the return on investment, thereby creating low adoption, consequently, slowing down the growth of global cell-based assays market in the forecast period. Similarly, a dearth of suitable professionals may hamper the cell-based assays market growth during the forecast period. Also, the lack of awareness about new assays for the research and development in emerging countries can further restrict the growth of global cell-based assays market.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Cell Based Assays Market"
The global cell-based assays market can be segmented by products and services, by application, by end user and by region. Based on products and services, the global cell-based assays market can be segmented into Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others. The assay and kits segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to increasing usage in biopharmaceutical companies for drug development across the globe.
Based on application, the market can be segmented into Clinical Research, Drug Discovery & Development, Others. The drug discovery and development segment is expected to dominate during the forecast period on account of increasing demand for novel therapeutic drugs for the treatment of different kind of diseases across the globe.
Major companies operating in global cell-based assays market are:
- Corning, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Lonza Group AG
- Promega Corporation
- F. Hoffmann-La Roche AG
- Merck KGaA
- Charles River Laboratories International, Inc.
- Menarini Silicon Biosystems, Inc.
For instance, in February 2020, Eurofins DiscoverX, the products company of Eurofins Discovery announced their partnership with VelaLabs of Vienna, Austria, in which Eurofins DiscoverX is granting the status of Bioassay Certified CRO to VelaLabs as a certified provider of PathHunter assay services.
In June 2020, PhenoVista Biosciences collaborated with Olympus to deliver 3D cell-based assay services for drug discovery.
For instance, in March 2022, Promega Corporation Collaborated with the FUJIFILM cellular dynamics to create novel assays to observe cellular biology in a system that better reflects how cells behave in the human body.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the Global Cell Based Assays market due to the increasing research and development activities in different research institutes collaboratively sponsored by academic grants and biopharmaceutical grants across the region. Similarly, the growing prevalence of lifestyle disorders such as arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, and others is expected to drive the growth of the market during the forecast period. Also, growing demand for drug testing such as toxicity studies, drug screening, in vitro screening, in vitro testing and others are also a major factor fueling the growth of the market. Furthermore, increasing development of healthcare expenditure and growing favorable reimbursement policies for the different diseases treatment are further contributing to the demand for cell-based assays. Besides, increasing investment by government organizations for development of new cell-based assays in the region is further expected to create lucrative opportunities for the market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others), By Application (Clinical Research, Drug Discovery & Development, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations), By Region and Competition”, has evaluated the future growth potential of global cell-based assays market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global cell-based assays market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
The global cell-based assays market size is expected to reach USD 28.2 Billion by 2028 and register a CAGR of 8.5% over the forecast period, according to the latest report by Reports and Data.
Some key factors such as growing funding by public and private sectors and increasing utilization of cell-based assays in drug discovery are driving global market revenue growth.
Cell-based assay is a technique used for analyzing living cells based on various parameters and also aids in measuring cell toxicity, motility, proliferation in diagnostics and drug discovery.
Overall high cost of assays due to high maintenance and instrument costs, lack of skilled professionals, and stringent regulations on reagent usage are some key factors expected to hamper growth of the cell-based assays market to some extent throughout the forecast period.
Top Companies Profiled in the Report Include:Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), and AAT Bioquest (US).Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3997Market Overview:The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.
Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past.
The Business Research Company’s Cell Based Assays Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.The Business Research Company published its Cell Based Assays Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global cell based assays market.
The report covers the cell based assays market’s segments- consumables, instruments, services, software, drug discovery, basic Research, ADME studies, predictive toxicology, pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CRO), automated handling, flow cytometry, label-free detection, high-throughput screening, reagents and media, cells and cell lines, probes and labels, microplates, microplate readers, high throughput screening, liquid handling systems, and others.Read Full Report @ https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-reportCell Based Assays Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It also compares the market’s historic and forecast growth.
It covers all the regions, key developed countries and major emerging markets.
It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
Cell-based assays Market are basically in-vitro assays which helps in the drug development process.
It is used for cytotoxic testing, determination of actual potency of drug product and drug substances and for the determination of mechanism of action of drug substances.
It can be of different types such as cell viability assays, cell proliferation assays and cell death assays.Cell-based assays are basically used for biological testing such as potency and mechanism of action of drug product.
Cell-based assays are the method to study living cell by considering different parameters such as pharmacokinetic study and pharmacodynamics study.
Cell viability assay is expected to dominate global cell-based assays with the increasing demand for measuring cellular metabolism and enzyme activity.Global cell based assays market is projected to register a substantial CAGR of 8.7% in the forecast period 2019 to 2026.Get Exclusive PDF Sample Copy of Cell-based assays Market Report (Including Full TOC, List of Tables & Figures, Chart) athttps://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cell-based-assays-marketMarket Drivers and Restraints:On the basis of type, the market is segmented into cell viability assay, cell proliferation assay, cytotoxicity assay, cell death assay, others.On the basis of product and services, the market is segmented consumables, services, instruments and software.On the basis of distribution channel, the market is segmented into direct and indirect.The major players covered in the Cell Based Assays Market Some of the major players operating in the global cell based assays market are GENERAL ELECTRIC, Danaher, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Inc., ATCC, Aurelia Bioscience Ltd, BD, BioAgilytix Labs, BioVision Inc., Cell Signaling Technology, Inc, Cisbio, Enzo Biochem Inc., Eurofins Scientific, LakePharma, Inc., Lonza, Miltenyi Biotec, XenoDiagnostics, LLC and others.Major TOC Of The ReportChapter One: Cell Based Assays Market OverviewChapter Two: Manufacturers ProfilesChapter Three: Global Cell Based Assays Market Competition, by PlayersChapter Four: Global Cell Based Assays Market Size by RegionsChapter Five: North America Cell Based Assays Market Revenue by CountriesChapter Six: Europe Cell Based Assays Market Revenue by CountriesChapter Seven: Asia-Pacific Cell Based Assays Market Revenue by CountriesChapter Eight: South America Cell Based Assays Market Revenue by CountriesFind More Competitor in TOC with Profile Overview Share Growth Analysis @https://www.databridgemarketresearch.com/toc/?dbmr=global-cell-based-assays-marketKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the global Cell Based Assays Market Analysis of market effect factors and their impact on the forecast and outlook of the global Cell Based Assays Market The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Cell Based Assays Market A roadmap of growth opportunities available in the global Cell Based Assays Market with the identification of key factorsThe exhaustive analysis of various trends of the global Cell Based Assays Market to help identify market developmentsAccess Full Report @https://www.databridgemarketresearch.com/reports/global-cell-based-assays-marketKey Questions Answered in Report:What is the key to the Cell Based Assays Market?What will the Cell Based Assays Market Demand and what will be Growth?What are the latest opportunities for Cell Based Assays Market in the future?What are the strengths of the key players?About Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the marketContact:Data Bridge Market ResearchTel: +1-888-387-2818Email: [email protected] Related Reports@Cardiac Monitoring and Cardiac Rhythm Management Devices MarketCorporate Wellness MarketHealthcare BPO Market
